Vanguard Global Advisers »

Seres Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $18k 2.0k 8.87

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Seres Therapeutics

Flagship Ventures Management
Susquehanna International
Vanguard Group
Vanguard Capital Management
Vontobel Holding
Marshall Wace
BlackRock
Caption Management
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
State Street Corporation
Lion Point Capital
Charles Schwab Investment Management
Morgan Stanley

View all funds holding Seres Therapeutics